<Part 2 of 5> Earnings Calendar - is it time for a Carnival (29Sep25)
Earnings Calendar (29Sep25)
The earnings from Carnival, Jefferies and Nike are interesting.
Let us research Carnival.
The security currently holds a “neutral” recommendation based on technical analysis indicators.
However, the prevailing analyst sentiment indicates a “Buy” rating. With a target price of $34.73. This target price suggests a potential upside of 13.41% from the current market price.
Financial Performance Review (2015-2024)
This analysis summarises the key financial metrics for the business over the ten years from 2015 to 2024, highlighting growth trends, the impact of the COVID-19 pandemic, and current financial health.
Revenue and Profitability Trends
The company demonstrated significant revenue growth and a notable recovery in operating profit by 2024.
Pandemic Impact (2020-2022)
The business incurred substantial losses during the COVID-19 pandemic:
-
Gross Loss: Over $2.6 billion in cumulative losses were recorded across 2020 and 2021.
-
Operating Losses: Significant operating losses were sustained for three consecutive years:
-
2020: $6.7 billion
-
2021: $6.8 billion
-
2022: $4.3 billion
Shareholder Returns and Efficiency
Earnings Per Share (EPS)
While the business has grown its revenue, EPS has seen a decline from 2015 to 2024.
-
2015 EPS: $2.26
-
2024 EPS: $1.44
-
Historical Peak: The best EPS recorded in the ten-year period was $4.44 in 2018.
Free Cash Flow and Capital Structure
-
Free Cash Flow CAGR: The 10-year Compound Annual Growth Rate for Free Cash Flow is 4.3%, aligning closely with the revenue growth rate.
-
Debt-to-Assets Ratio: The ratio stands at 0.4, indicating a moderate level of leverage.
-
Dividends: The company has suspended the issuance of dividends since 2021.
The upcoming earnings release forecasts an Earnings Per Share (EPS) of $1.32 and revenue of $8.09 billion.
Beyond these core financial metrics, the market outlook provided by the company is a critical factor for investment evaluation.
The business has shown a good recovery from the impacts of COVID-19. Furthermore, its current Price-to-Earnings (P/E) ratio of 16.4 makes it an attractive valuation on a standalone basis.
Despite the positive recovery and appealing valuation, a final investment decision is contingent upon reviewing the company’s official outlook and guidance.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
- Valerie Archibald·09-29TOPFor long run, it is a buy but after ER on 9/29/25, it will tank a bit.1Report
- Enid Bertha·09-29TOPSell at your own peril. CCL is a screaming BUY.1Report
- NormaHansen·09-29TOPInteresting analysis1Report